Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...

(NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Bio-Rad ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cabaletta Bio ( (CABA)) has shared an ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "GCC Liquid Biopsy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's ...

WELLESLEY HILLS, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...

BOSTON - Vor Bio (NASDAQ:VOR), whose stock has surged over 137% in the past year and 20% in the last week alone, announced Monday that clinical data from a Phase 3 study of telitacicept in adults with ...

Health tech company Datavant is continuing its acquisition spree with plans to buy Israeli startup DigitalOwl, an artificial-intelligence-powered platform for insurance and legal professionals. With ...

New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to proprietary structural data to train a large language model. Each of the ...